JAPAN, US, EURO PATENT AGREEMENT

9 March 1992

At a meeting late last month of the heads of the Japanese, US and European Patent Office, agreement was reached for cooperation on the integration of the region's patent systems in order to handle the escalating number of patent applications.

JPA Commissioner Wataru Fukasawa announced at a press conference that the three parties had agreed to use: the same information retrieval tools to prevent duplication on searching; to exchanges of staff in order to study how to streamline investigations; and to set up a working group to decide on details.

In this respect, the three offices agreed to provide information for those using the proposed databases at the lowest possible cost and to unify fees for providing information in areas of DNA databases, stores information related to genetic subjects and first pages of patent documents.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight